Merck No Longer in Talks to Buy Revolution Medicines

Date:




The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Garth Brooks’ Next Tour Date Announced

Garth Brooks just announced city No. 7 on his...

China’s Geely Unveils EV Charging Under Five Minutes

The automaker rivals ultrafast charging from BYD as automakers...